What can we help you find?
Treatment Considerations for Managing a Patient With Congenital Plasminogen Deficiency Who Becomes Pregnant
Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the treatment considerations necessary to properly manage a patient with congenital plasminogen deficiency after she became pregnant.
In a recent interview with Pharmacy Times, Barbara Giacomelli, BS Pharm, PharmD, discussed the trends she hopes to see in the pharmacy field in 2021 and where she sees the landscape changing.
Patrick Campbell, PharmD, PhD, the senior director of research at the Pharmacy Quality Alliance, discusses why sending a short video to a patient’s phone can improve primary medication adherence and why it’s more effective than text messages.
Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on how pharmacies and their patients are affected by issues regarding the regulation of the sale of 340B discounted drugs.
A panel of experts share the ISTH recommendation and the pharmacist’s role in helping identify patients at increased risk of VTE.
Having a shared cultural understanding allows the pharmacy to make medical and educational interventions relevant to the patient and allows patients to actively participate in their care.
Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a lawsuit filed against the HHS and HRSA regarding the sale of 340B discounted drugs.
Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the details of a patient who had a successful pregnancy despite documented infertility due to congenital plasminogen deficiency.
Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.
Panelists review the tools, specifically the Padua and IMPROVE models used to identify VTE risks.
Randall A. Oyer, MD, discusses rising cancer mortality during the coronavirus disease 2019 (COVID-19) pandemic and what that means for cancer care.
Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the disease impact on the gynecologic system and how often patients become infertile due to this impact.